Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC's “Halftime Report” to detail his latest portfolio moves.
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the ideal 'dogcatcher' standard for fair-priced, safer dividend stocks. Analyst projections suggest the
UnitedHealth's (NYSE: UNH) turbulent run in 2025 is escalating after the firm reported disappointing Q2 earnings results, but an AI platform has identified strategic entry points for long-term investo

UnitedHealth Faces Long Road to Recovery

05:30am, Wednesday, 30'th Jul 2025
Returning CEO Stephen Hemsley is lowering expectations, but perhaps not enough.
My bearish thesis on UnitedHealth Group Incorporated is playing out, with margins and earnings deteriorating as expected after Q2 FY25 results. The onus is on management to prove this is the bottom. M
Despite a double earnings miss, I am upgrading UnitedHealth Group Incorporated stock to Strong Buy due to its long-term growth potential and resilient fundamentals. UNH's current valuation prices in e
UnitedHealth Group Incorporated (NYSE:UNH ) Q2 2025 Earnings Conference Call July 29, 2025 8:45 AM ET Company Participants Bobby Hunter - CEO of Government Programs & Head of Medicare Insurance - Corp

Why UnitedHealth Stock Is Sinking Today

02:33pm, Tuesday, 29'th Jul 2025
Shares of UnitedHealth Group (UNH -5.91%) are falling on Tuesday, down 5.4% as of 2:20 p.m. ET. The drop comes as the S&P 500 (^GSPC -0.25%) declined 0.3% and the Nasdaq Composite (^IXIC -0.21%) fell
The Investment Committee debate some of their stocks on the move lower.

UnitedHealth Group Posts Q2 Revenue Gain

01:26pm, Tuesday, 29'th Jul 2025
UnitedHealth Group (UNH -5.10%), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its ear
UnitedHealth Group Incorporated's Q2 results show revenue growth but sharply lower earnings, with margins under pressure from higher medical costs and Medicare Advantage miscalculations. Management re
UnitedHealth's stock decline is overdone; DOJ investigation risk is likely manageable, with historical precedent suggesting a fine and agreement as the worst-case outcome. Medicaid margin pressures ar
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday.
UNH misses Q2 earnings estimates as surging medical costs slash EPS 40%, despite revenue growth and Optum Rx strength.
Live Updates Live Coverage Updates appear automatically as they are published. Investment Shifts: Portfolio Sales Paused, AI and Optum Insight Prioritized (conference call) 10:31 am “We’ve halted
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE